索宝蛋白(603231.SH):2025年三季报净利润为1.47亿元

Core Insights - The company reported a total revenue of 1.24 billion yuan for Q3 2025, ranking 18th among disclosed peers [1] - The net profit attributable to shareholders was 147 million yuan, with net cash inflow from operating activities at 129 million yuan, ranking 15th among peers [1] Financial Performance - The latest debt-to-asset ratio is 9.67%, an increase of 0.95 percentage points from the previous quarter and 0.45 percentage points from the same period last year [3] - The latest gross profit margin is 17.91%, down 0.83 percentage points from the previous quarter [3] - The return on equity (ROE) stands at 7.47% [3] Earnings and Ratios - The diluted earnings per share (EPS) is 0.77 yuan [4] - The total asset turnover ratio is 0.58 times, ranking 14th among disclosed peers [4] - The inventory turnover ratio is 3.78 times, a decrease of 1.13 times from the same period last year, representing a year-on-year decline of 22.99% [4] Shareholder Structure - The number of shareholders is 19,000, with the top ten shareholders holding a total of 132 million shares, accounting for 68.85% of the total share capital [4] - The largest shareholder is Shandong Wande Fu Industrial Group Co., Ltd., holding 43.2 million shares [4]